BCRX logo

BioCryst Pharmaceuticals (BCRX) Non Current Assets

Annual Non Current Assets

$20.99 M
-$12.51 M-37.33%

December 31, 2023

Summary

Performance

1-Year Change

-37.33%

3-Year Change

+92.34%

5-Year Change

-35.38%

15-Year Change

-60.29%

BCRX Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.44%
BCRX annual long term assets is higher than 49.44% of companies in Healthcare sector

High & Low

All-time High

$58.56 M
BCRX annual long term assets is currently -64.15% below its historical high of $58.56 million

3-Year Low

$20.99 M
BCRX annual long term assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BCRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
BCRX next annual earnings announcement has not yet been scheduled

OtherBCRXbalance sheetmetrics:

Annual Total Assets

$516.96 M
BCRX annual total assets is $516.96 million

Annual Current Assets

$447.74 M
BCRX annual total current assets is $447.74 million

Annual Total Liabilities

$972.49 M
BCRX annual total liabilities is $972.49 million

Annual Total Long Term Liabilities

$822.50 M
BCRX annual total long term liabilities is $822.50 million

Quarterly Non Current Assets

$64.13 M
-$44.83 M-41.15%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+392.54%

5-Year Change

+448.25%

BCRX Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.3%
BCRX quarterly long term assets is higher than 64.3% of companies in Healthcare sector

High & Low

All-time High

$108.96 M
BCRX quarterly long term assets is currently -41.15% below its historical high of $108.96 million

3-Year Low

$15.69 M
BCRX quarterly long term assets is currently +308.86% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BCRX next earnings announcement has not yet been scheduled

OtherBCRXbalance sheetmetrics:

Quarterly Total Assets

$491.25 M
BCRX quarterly total assets is $491.25 million

Quarterly Current Assets

$424.12 M
BCRX quarterly total current assets is $424.12 million

Quarterly Total Liabilities

$959.82 M
BCRX quarterly total liabilities is $959.82 million

Quarterly Long Term Liabilities

$806.25 M
BCRX quarterly total long term liabilities is $806.25 million

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

BCRX Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-37.3%0.0%
3 y3 years+92.3%+392.5%
5 y5 years-35.4%+448.3%

BCRX Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-37.3%at low-41.1%+308.9%
5 y5-year-37.3%+92.3%-41.1%+501.6%
alltimeall time-64.2%+1399.6%-41.1%+5244.1%

BioCryst Pharmaceuticals Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$64.13 M(-41.1%)
Jun 2024
-
$108.96 M(+424.1%)
Mar 2024
-
$20.79 M(-1.0%)
Dec 2023
$447.74 M(-13.3%)
$20.99 M(+2.6%)
Sep 2023
-
$20.46 M(+8.7%)
Jun 2023
-
$18.83 M(-0.1%)
Mar 2023
-
$18.85 M(-43.7%)
Dec 2022
$516.50 M(-8.8%)
$33.50 M(-32.5%)
Sep 2022
-
$49.59 M(+216.2%)
Jun 2022
-
$15.69 M(-2.0%)
Mar 2022
-
$16.01 M(-27.3%)
Dec 2021
$566.14 M(+74.8%)
$22.02 M(+69.1%)
Sep 2021
-
$13.02 M(+13.4%)
Jun 2021
-
$11.48 M(+7.7%)
Mar 2021
-
$10.66 M(-2.3%)
Dec 2020
$323.80 M(+97.0%)
$10.91 M(-20.8%)
Sep 2020
-
$13.79 M(+26.9%)
Jun 2020
-
$10.87 M(-1.9%)
Mar 2020
-
$11.08 M(+1.3%)
Dec 2019
$164.34 M(+43.7%)
$10.94 M(-6.5%)
Sep 2019
-
$11.70 M(-7.4%)
Jun 2019
-
$12.63 M(-48.9%)
Mar 2019
-
$24.69 M(-24.0%)
Dec 2018
$114.35 M(-8.8%)
$32.49 M(-18.4%)
Sep 2018
-
$39.81 M(-9.5%)
Jun 2018
-
$43.98 M(-14.1%)
Mar 2018
-
$51.22 M(-3.1%)
Dec 2017
$125.39 M(+87.2%)
$52.87 M(+227.9%)
Sep 2017
-
$16.12 M(-24.1%)
Jun 2017
-
$21.25 M(+32.7%)
Mar 2017
-
$16.01 M(-30.0%)
Dec 2016
$66.99 M(+5.0%)
$22.86 M(-14.9%)
Sep 2016
-
$26.87 M(-25.6%)
Jun 2016
-
$36.10 M(-31.2%)
Mar 2016
-
$52.46 M(-10.4%)
Dec 2015
$63.79 M(-28.6%)
$58.56 M(+7.5%)
Sep 2015
-
$54.45 M(+26.4%)
Jun 2015
-
$43.09 M(-11.2%)
Mar 2015
-
$48.50 M(+2.0%)
Dec 2014
$89.34 M(+112.1%)
$47.53 M(+2299.3%)
Sep 2014
-
$1.98 M(-46.8%)
Jun 2014
-
$3.73 M(-51.3%)
Mar 2014
-
$7.66 M(+13.5%)
Dec 2013
$42.12 M(+0.3%)
$6.75 M(+6.0%)
Sep 2013
-
$6.37 M(-0.3%)
Jun 2013
-
$6.39 M(-44.4%)
Mar 2013
-
$11.49 M(-25.7%)
Dec 2012
$41.98 M(-20.6%)
$15.46 M(-11.7%)
Sep 2012
-
$17.51 M(-43.8%)
Jun 2012
-
$31.17 M(+14.9%)
Mar 2012
-
$27.14 M(-7.5%)
Dec 2011
$52.86 M(-39.5%)
$29.35 M(-8.5%)
Sep 2011
-
$32.06 M(+12.4%)
Jun 2011
-
$28.54 M(+27.9%)
Mar 2011
-
$22.32 M(+1.3%)
Dec 2010
$87.42 M(-21.3%)
$22.03 M(+2.0%)
Sep 2010
-
$21.59 M(-40.6%)
Jun 2010
-
$36.35 M(+14.1%)
Mar 2010
-
$31.86 M(+2.2%)
Dec 2009
$111.02 M
$31.17 M(+214.8%)
Sep 2009
-
$9.90 M(+36.7%)
DateAnnualQuarterly
Jun 2009
-
$7.24 M(-3.1%)
Mar 2009
-
$7.47 M(-22.7%)
Dec 2008
$75.02 M(-18.2%)
$9.67 M(-49.8%)
Sep 2008
-
$19.24 M(-63.0%)
Jun 2008
-
$52.03 M(+0.3%)
Mar 2008
-
$51.88 M(+1.7%)
Dec 2007
$91.70 M(+100.3%)
$51.01 M(+2.9%)
Sep 2007
-
$49.59 M(+83.7%)
Jun 2007
-
$27.00 M(+30.9%)
Mar 2007
-
$20.63 M(-9.1%)
Dec 2006
$45.79 M(-43.5%)
$22.70 M(-28.0%)
Sep 2006
-
$31.54 M(+3.0%)
Jun 2006
-
$30.63 M(+0.7%)
Mar 2006
-
$30.43 M(+67.7%)
Dec 2005
$81.10 M(+239.7%)
$18.15 M(+171.9%)
Sep 2005
-
$6.67 M(-30.7%)
Jun 2005
-
$9.63 M(+23.8%)
Mar 2005
-
$7.78 M(-9.5%)
Dec 2004
$23.87 M(+15.3%)
$8.60 M(-40.1%)
Sep 2004
-
$14.36 M(-15.8%)
Jun 2004
-
$17.06 M(+1.2%)
Mar 2004
-
$16.86 M(+79.6%)
Dec 2003
$20.70 M(-17.0%)
$9.39 M(-22.2%)
Sep 2003
-
$12.06 M(+24.8%)
Jun 2003
-
$9.66 M(-35.6%)
Mar 2003
-
$15.01 M(-8.3%)
Dec 2002
$24.93 M(-23.1%)
$16.37 M(+1.0%)
Sep 2002
-
$16.21 M(-19.5%)
Jun 2002
-
$20.15 M(-13.1%)
Mar 2002
-
$23.20 M(-13.1%)
Dec 2001
$32.40 M(+25.8%)
$26.69 M(-14.5%)
Sep 2001
-
$31.22 M(-3.8%)
Jun 2001
-
$32.44 M(-4.5%)
Mar 2001
-
$33.98 M(-24.6%)
Dec 2000
$25.76 M(+4.7%)
$45.07 M(-1.9%)
Sep 2000
-
$45.92 M(-2.8%)
Jun 2000
-
$47.23 M(-2.5%)
Mar 2000
-
$48.43 M(-0.8%)
Dec 1999
$24.60 M(+7.4%)
$48.80 M(+662.5%)
Sep 1999
-
$6.40 M(-22.9%)
Jun 1999
-
$8.30 M(+13.7%)
Mar 1999
-
$7.30 M(+17.7%)
Dec 1998
$22.90 M(+16.2%)
$6.20 M(+287.5%)
Sep 1998
-
$1.60 M(-5.9%)
Jun 1998
-
$1.70 M(-57.5%)
Mar 1998
-
$4.00 M(-41.2%)
Dec 1997
$19.70 M(-29.9%)
$6.80 M(+47.8%)
Sep 1997
-
$4.60 M(+12.2%)
Jun 1997
-
$4.10 M(-61.7%)
Mar 1997
-
$10.70 M(+18.9%)
Dec 1996
$28.10 M(+140.2%)
$9.00 M(+650.0%)
Sep 1996
-
$1.20 M(-7.7%)
Jun 1996
-
$1.30 M(0.0%)
Mar 1996
-
$1.30 M(-7.1%)
Dec 1995
$11.70 M(+5.4%)
$1.40 M(0.0%)
Sep 1995
-
$1.40 M(-6.7%)
Jun 1995
-
$1.50 M(-6.3%)
Mar 1995
-
$1.60 M(-5.9%)
Dec 1994
$11.10 M
$1.70 M(0.0%)
Sep 1994
-
$1.70 M(-5.6%)
Jun 1994
-
$1.80 M(-59.1%)
Mar 1994
-
$4.40 M

FAQ

  • What is BioCryst Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual non current assets year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly non current assets year-on-year change?

What is BioCryst Pharmaceuticals annual long term assets?

The current annual non current assets of BCRX is $20.99 M

What is the all time high annual non current assets for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual long term assets is $58.56 M

What is BioCryst Pharmaceuticals annual non current assets year-on-year change?

Over the past year, BCRX annual long term assets has changed by -$12.51 M (-37.33%)

What is BioCryst Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of BCRX is $64.13 M

What is the all time high quarterly non current assets for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly long term assets is $108.96 M

What is BioCryst Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, BCRX quarterly long term assets has changed by $0.00 (0.00%)